Review article · 2013
Conference abstractPublished 12 Sep 2016
Effect of genetic, patient and clinical factors on statin-related myotoxicity
Newcastle upon Tyne, United Kingdom.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Although statins are generally well-tolerated, statin associated musculoskeletal symptoms (SAMS) are relatively common. True statin-related myotoxicity (SRM) is much less common and rhabdomyolysis, the severest consequence of myopathy, is a rare event. Genetic factors associated with enhanced statin systemic exposure and muscular availability increase the risk of severe myopathy; however it is not clear whether the same or different genetic factors operate across the spectrum of SRM from myalgia to milder myopathy, as encountered in routine practice. The current study examined associations between clinical and genetic factors and SRM in a case-control design study in patients at high cardiovascular risk. 120 SRM cases (who discontinued statins due to intolerable statin related muscle symptoms) and 481 statin tolerant controls (treated with either 40 mg simvastatin or 80 mg atorvastatin daily) were studied. The association between 12 single nucleotide polymorphisms (SNPs) in nine candidate genes [i.e., SLCO1B1, ABCC2, ABCG2, CYP3A4, COQ2, glycine amidinotransferase (GATM), glutathione peroxidases 1 and 4 (GPX1 and GPX4), SLC16A1, SLC16A3] and patient factors (age, sex, BMI, comorbidities and concurrent therapy) with SRM was evaluated. Of the 12 SNPs genotyped, only rs4149056 in SLCO1B1 was associated with SRM (P = 0.031, P = 0.014 in univariate and binary logistic regression analysis, respectively) with odds ratio of 1.60 (95 % CI= 1.05-2.45) and this association was influenced by sex (P= 0.006). In multivariate logistic regression analyses of data only SLCO1B1 rs4149056 genotype (OR=1.72, 95% CI: 1.15- 2.59, P=0.014) and sex (OR=1.72, 95% CI =1.15 - 2.59, P=0.006) were independently associated with SRM. We conclude that genetic factors associated with statin systemic exposure are implicated in the full spectrum of SRM. However among the genetic variants studied here, only SLCO1B1 rs4149056 warrants further evaluation for the identification of patients who may be susceptible to myopathy.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 7 Aug 2023
Genetic Factors in Aging: Understanding the Impact on Age-Related Disorders
Conference abstract · 25 Apr 2023
Association Analysis of Kruppel like factor 1 (KLF1) And Secretion Associated Ras Related GTPase-1A (SAR1A) Genetic Polymorphisms with Hydroxyurea Response In andbeta;-Thalassemia Patients
Other · 30 Jun 2021
Association Analysis of Kruppel like factor 1 (KLF1) and Secretion Association Ras Related GTPase 1A (SAR1A) Genetic Polymorphisms with Hydroxyurea Response in β-Thalassemia Patients
Conference abstract · 29 Oct 2018
Genetic variations in tumor necrosis factor related apoptosis-inducing ligand-1 and the susceptibility to B cell Non-Hodgkin lymphoma in Egypt
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Farhad Kamali”
